Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)

Market Cap	8.14B -34.5%
Revenue (ttm)	2.45B -8.7%
Net Income	251.01M -40.3%
EPS	1.08 -40.0%
Shares Out	n/a
PE Ratio	32.43
Forward PE	n/a
Dividend	1.00 (2.57%)
Ex-Dividend Date	Oct 16, 2025

Volume	284,849
Average Volume	501,728
Open	38.94
Previous Close	39.20
Day's Range	38.78 - 39.07
52-Week Range	37.25 - 58.97
Beta	0.60
RSI	42.49
Earnings Date	Mar 20, 2026

About SHA:688366

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,156
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688366

Financial Performance

In 2025, SHA:688366's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.